Free Trial
NYSE:UPC

Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Universe Pharmaceuticals logo
$4.74 +0.09 (+1.83%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Universe Pharmaceuticals Stock (NYSE:UPC)

Key Stats

Today's Range
$4.70
$4.82
50-Day Range
$2.85
$6.29
52-Week Range
$2.51
$2,592.00
Volume
2,136 shs
Average Volume
169,116 shs
Market Capitalization
$203,605.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Receive UPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

UPC Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
See More Headlines

UPC Stock Analysis - Frequently Asked Questions

Universe Pharmaceuticals' stock was trading at $24.40 at the beginning of 2025. Since then, UPC shares have decreased by 80.4% and is now trading at $4.78.
View the best growth stocks for 2025 here
.

Universe Pharmaceuticals's stock reverse split before market open on Wednesday, November 13th 2024. The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO.

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Universe Pharmaceuticals investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF) and GE Aerospace (GE).

Company Calendar

Today
5/28/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:UPC
Fax
N/A
Employees
220
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$23.02 million
Price / Cash Flow
N/A
Book Value
$163.50 per share
Price / Book
0.03

Miscellaneous

Free Float
731,000
Market Cap
$199,950.00
Optionable
Not Optionable
Beta
1.52
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSE:UPC) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners